These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16377304)

  • 21. [Placebo effect in randomized clinical trials in neuropathic pain patients].
    Dobrogowski J; Ciupik M; Przeklasa-Muszyńska A; Wordliczek J
    Folia Med Cracov; 2007; 48(1-4):125-44. PubMed ID: 19051699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychobiology of the placebo response.
    Klosterhalfen S; Enck P
    Auton Neurosci; 2006 Apr; 125(1-2):94-9. PubMed ID: 16515893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The story of placebo effects in medicine: evidence in context.
    Wampold BE; Imel ZE; Minami T
    J Clin Psychol; 2007 Apr; 63(4):379-90; discussion 405-8. PubMed ID: 17279527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression to the mean in substance use disorder treatment research.
    Finney JW
    Addiction; 2008 Jan; 103(1):42-52. PubMed ID: 17999707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Placebo response in functional bowel disorders].
    Enck P; Klosterhalfen S
    Z Gastroenterol; 2006 Mar; 44(3):257-66. PubMed ID: 16514572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).
    Dzau VJ; Antman EM; Black HR; Hayes DL; Manson JE; Plutzky J; Popma JJ; Stevenson W
    Circulation; 2006 Dec; 114(25):2850-70. PubMed ID: 17179034
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Manchikanti L, Singh V, Falco FJ, et al. Cervical medial branch blocks for chronic cervical facet joint pain: a randomized, double-blind, controlled trial with one-year follow-up. Spine 2008;33:1813-20.
    Smuck M; Levin JH
    Spine (Phila Pa 1976); 2009 May; 34(10):1116; author reply 1116-7. PubMed ID: 19404184
    [No Abstract]   [Full Text] [Related]  

  • 28. [Critical of the additive model of the randomized controlled trial].
    Boussageon R; Gueyffier F; Bejan-Angoulvant T; Felden-Dominiak G
    Therapie; 2008; 63(1):29-35. PubMed ID: 18387273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary intervention in China: registries and trials.
    Gao R
    Indian Heart J; 2007; 59(2 Suppl B):B16-9. PubMed ID: 19153430
    [No Abstract]   [Full Text] [Related]  

  • 30. Placebo: new insights into an old enigma.
    Ernst E
    Drug Discov Today; 2007 May; 12(9-10):413-8. PubMed ID: 17467578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.
    Cogger KO
    J Clin Psychopharmacol; 2007 Aug; 27(4):418-20. PubMed ID: 17632240
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Polman CH; Reingold SC; Barkhof F; Calabresi PA; Clanet M; Cohen JA; Cutter GR; Freedman MS; Kappos L; Lublin FD; McFarland HF; Metz LM; Miller AE; Montalban X; O'Connor PW; Panitch H; Richert JR; Petkau J; Schwid SR; Sormani MP; Thompson AJ; Weinshenker BG; Wolinsky JS
    Neurology; 2008 Mar; 70(13 Pt 2):1134-40. PubMed ID: 18362273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chop-lump tests for vaccine trials.
    Follmann D; Fay MP; Proschan M
    Biometrics; 2009 Sep; 65(3):885-93. PubMed ID: 19210727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature and power of the placebo effect.
    Miller FG; Rosenstein DL
    J Clin Epidemiol; 2006 Apr; 59(4):331-5. PubMed ID: 16549251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What are the odds?
    Grunkemeier GL; Wu Y
    Ann Thorac Surg; 2007 Apr; 83(4):1240-4. PubMed ID: 17383319
    [No Abstract]   [Full Text] [Related]  

  • 36. A meta-regression analysis shows no impact of design characteristics on outcome in trials on tension-type headaches.
    Verhagen AP; de Vet HC; Willemsen S; Stijnen T
    J Clin Epidemiol; 2008 Aug; 61(8):813-8. PubMed ID: 18359608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninferiority hypotheses and choice of noninferiority margin.
    Ng TH
    Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-only analysis of treatment-covariate interactions in clinical trials.
    Vittinghoff E; Bauer DC
    Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of placebo in headache research.
    Diener HC; Schorn CF; Bingel U; Dodick DW
    Cephalalgia; 2008 Oct; 28(10):1003-11. PubMed ID: 18727647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.